| Synonyms: | |
| Status: | Approved (2001) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | C02KX01 |
| UNII: | Q326023R30 |
| InChI Key | GJPICJJJRGTNOD-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C27H29N5O6S |
| Molecular Weight | 551.63 |
| AlogP | 4.2 |
| Hydrogen Bond Acceptor | 10.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 10.0 |
| Polar Surface Area | 145.65 |
| Molecular species | ACID |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 39.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Endothelin receptor, ET-A/ET-B antagonist |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | - | - | - | ||
|
Enzyme
Transferase
|
- | 60830 | - | - | 4.397-12.14 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | - | -7.67-22.48 | |
|
Membrane receptor
Family A G protein-coupled receptor
Peptide receptor (family A GPCR)
Short peptide receptor (family A GPCR)
Endothelin receptor
|
- | 4.7-1584.89 | 39.81-72.44 | 3.67-8 | 22.54 | |
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 1
Nuclear hormone receptor subfamily 1 group I
Nuclear hormone receptor subfamily 1 group I member 2
|
8900-14100 | - | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC10 family of sodium-bile acid co-transporters
|
- | 30000000 | - | - | - | |
|
Transporter
Primary active transporter
ATP-binding cassette
ABCB subfamily
|
- | 22000-38100 | - | 12000 | - | |
|
Transporter
Primary active transporter
ATP-binding cassette
ABCC subfamily
|
- | 22000 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hypertension, Pulmonary | 4 | D006976 | ClinicalTrials |
| Eisenmenger Complex | 3 | D004541 | ClinicalTrials |
| Idiopathic Pulmonary Fibrosis | 3 | D054990 | ClinicalTrials |
| Optic Neuropathy, Ischemic | 3 | D018917 | ClinicalTrials |
| Persistent Fetal Circulation Syndrome | 3 | D010547 | ClinicalTrials |
| Ulcer | 3 | D014456 | ClinicalTrials |
| Diabetes Mellitus, Type 2 | 3 | D003924 | ClinicalTrials |
| Heart Septal Defects, Atrial | 3 | D006344 | ClinicalTrials |
| Hernias, Diaphragmatic, Congenital | 2 | D065630 | ClinicalTrials |
| Asthma | 2 | D001249 | ClinicalTrials |
| Hermanski-Pudlak Syndrome | 2 | D022861 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Pulmonary Disease, Chronic Obstructive | 2 | D029424 | ClinicalTrials |
| Hypoplastic Left Heart Syndrome | 2 | D018636 | ClinicalTrials |
| Liver Cirrhosis | 2 | D008103 | ClinicalTrials |
| Fever | 1 | D005334 | ClinicalTrials |
| Diabetes Mellitus | 1 | D003920 | ClinicalTrials |
| Pancreatic Neoplasms | 1 | D010190 | ClinicalTrials |
| Heart Failure | 1 | D006333 | ClinicalTrials |
| Glaucoma | 1 | D005901 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Sleep Apnea Syndromes | 1 | D012891 | ClinicalTrials |
| Mitral Valve Stenosis | 1 | D008946 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 51450 |
| ChEMBL | CHEMBL957 |
| DrugBank | DB00559 |
| DrugCentral | 392 |
| EPA CompTox | DTXSID7046627 |
| FDA SRS | Q326023R30 |
| Human Metabolome Database | HMDB14699 |
| Guide to Pharmacology | 3494 |
| PDB | K86 |
| PharmGKB | PA10034 |
| PubChem | 104865 |
| SureChEMBL | SCHEMBL4218 |
| ZINC | ZINC000001538857 |